← Evidence map

Observational studyBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer.

Catherine Pham et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37747629